Suggestions
Roel Sterken
Chief Executive Officer at Biogazelle
Professional Background
Roel Sterken is a highly esteemed professional in the life sciences sector, renowned for his deep expertise in genetics and molecular biology. His career spans both the agrobiotech and healthcare industries, allowing him to deftly navigate and contribute to a variety of scientific and business landscapes. As a Chief Executive Officer at Biogazelle, Roel has made significant strides in managing end-to-end drug development processes while simultaneously establishing innovative biotech startups across the globe, including initiatives in the United States, Europe, and Australia.
Known for his top-tier publication record, Roel's analytical aptitude is matched by a diverse skill set, which includes project management, business development, and pre-clinical as well as clinical drug evaluation and development. He possesses a keen understanding of intellectual property (IP) management, company due diligence, scientific design and writing, business strategy, and venture capital. His unique blend of scientific knowledge and business acumen enables Roel to effectively lead teams and projects in a manner that promotes innovation and drives success.
Beyond his technical abilities, Roel is a strong advocate for the power of clear communication and teamwork, believing these principles are crucial in fostering collaboration and achieving collective goals. His passion for entrepreneurship and innovation shines through in every venture he undertakes.
Education and Achievements
Roel Sterken's educational background is exceptionally impressive. He graduated with a Master of Business Administration (MBA) from Solvay Business School, where he achieved the prestigious honor of Summa Cum Laude, showcasing his academic excellence and dedication. Furthermore, he pursued an Executive Master of Science in Technology Management with a focus on Knowledge Management and Emerging Technologies at Columbia University in the City of New York, gaining valuable insights into managing cutting-edge technologies and their implications in modern business.
Roel's academic journey began with a PhD in Molecular Biology, with a concentration in Plant Genetics from Ghent University. His pursuit of knowledge extended through a pre-doctoral internship in Population Genomics at New York University, equipping him with advanced skills in genomics and data analysis.
Additionally, he earned both a Bachelor of Science (BS) and Master of Science (MS) in Biology and Biotechnology, graduating Cum Laude from Universiteit Gent. His diverse educational experiences have provided him with a solid foundation to excel in both scientific research and business management.
Notable Professional Achievements
Throughout his career, Roel Sterken has held various significant positions that demonstrate his leadership capabilities and expertise. As a former Board Member at the Flanders Future Tech Fund (FFTF), he contributed to advancing the interests of technology and innovation in Flanders.
Roel also founded RS2B bvba, where he served as Managing Director, showcasing his entrepreneurial spirit and his drive to create impactful biotech solutions. At Space Refinery, he served as Business Director and Co-founder, further solidifying his reputation as a forward-thinking innovator.
In response to the global pandemic, Roel played a pivotal role at Biogazelle as the CO Covid-19, where he navigated the complexities of developing solutions for COVID-19, showcasing his commitment to addressing public health challenges.
His experience extends into consultancy roles, where he provided strategic business guidance at Biogazelle and served as a Senior Business and Strategy Advisor at the Janssen Human Microbiome Institute. His strategic insights and business acumen have also benefited organizations like BiOncotech Therapeutics, where he acted as a Board Observer, and DROIA Oncology Ventures, where he held the position of Investment Manager and Project Development Manager.
Roel's research experience is remarkable, with positions as a Post-doctoral Researcher at Columbia University Medical Center and as a Predoctoral researcher at VIB, where he harnessed his scientific expertise to contribute to research that has driven the life sciences field forward.
Achievements
